Skip to main content
painEvidence: Grade B

Using Your MitoRed MitoPRO 750 for Neuropathy Treatment

Published: Last updated:

Device-specific protocol for Neuropathy using the MitoRed MitoRed MitoPRO 750 (630/660/830/850nm, 168 mW/cm²)

Your MitoRed MitoPRO 750 Protocol for Neuropathy

Wavelengths

630nm, 660nm, 830nm, 850nm

Session Time

1 min

Target Dose

12 J/cm²

Distance

6 inches

Frequency

3-5x/week

Timeline

4-12 weeks

Why MitoRed MitoPRO 750 for Neuropathy?

The MitoRed MitoRed MitoPRO 750 emits at 630nm and 660nm and 830nm and 850nm, which provides a excellent match for Neuropathy treatment. Research for this condition recommends 830nm, 850nm.

At 168 mW/cm² irradiance (at the recommended distance of 6 inches), you'll need approximately 1 minutes per session to reach the target dose of 12 J/cm². This falls within the recommended range of 4-20 J/cm² for Neuropathy.

The MitoRed MitoPRO 750's half body coverage area makes it suitable for treating larger treatment zones. For Neuropathy, position the device at 6 inches from the target area.

MitoRed MitoPRO 750 Quick Specs

Price

$699

LEDs

150

Power

300W

FDA

Not registered

Evidence for Neuropathy

Near-infrared therapy at 830-850nm shows encouraging results for diabetic peripheral neuropathy, with some studies reporting improved sensation and reduced pain scores. Dose: 4-20 J/cm², 15-30 minutes, 3-5x/week for 4-12 weeks. Evidence grade: B (moderate — small but consistent study results).

Same Condition, Different Devices

Research Basis

This content is informed by 47+ published peer-reviewed studies on photobiomodulation.